WHO Prequalifies First Ever Biosimilar
Paves Way For Ontruzant's Accelerated Registration In 41 Countries
Executive Summary
Samsung Bioepis’ Ontruzant trastuzumab biosimilar has become the first biosimilar to be prequalified by the World Health Organization.
You may also be interested in...
WHO Prequalifies Celltrion’s Rituximab
Celltrion's Truxima has become the first rituximab biosimilar, and just the second biosimilar overall, to be prequalified by the World Health Organization.
WHO Kick-Starts Pilot For Prequalification Of Biologics/Biosimilars
Manufacturers are being invited to submit expressions of interest in relation to two anticancer monoclonal antibodies on the WHO's essential list of medicines.
Study Offers Support For Biosimilar-To-Biosimilar Switching
A new paper has examined the issue of biosimilar-to-biosimilar switching, concluding that it is a safe and effective clinical practice but highlighting a lack of current health authority regulations or guidance on the subject.